Adding SBRT to Sorafenib Boosts Survival in Liver Cancer
Adding stereotactic body radiation therapy (SBRT) to treatment with sorafenib improved overall survival and progression-free survival as well as quality of life.
Medscape Medical News
source https://www.medscape.com/viewarticle/987324?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/987324?src=rss
Comments
Post a Comment